계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Xanodyne
company
About
Xanodyne Pharmaceuticals is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.
- 51 - 100
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $87.78M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$87.78M
Xanodyne has raised a total of
$87.78M
in funding over 2 rounds. Their latest funding was raised on
Oct 30, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 30, 2009 | Series Unknown | $87.78M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Xanodyne is funded by 1 investors.
Perseus-Soros Biopharmaceutical Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Perseus-Soros Biopharmaceutical Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
